Delivery Order SPE2DB22D3301-SPE2DB25FX8JT

Award Date 1/13/25
Potential Completion Date 1/14/25
Potential Value $3.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,977.88 firm fixed-price delivery order is for the supply of 4566188071 ONDANSETRON ODT 8 MG TABLET 30S. The contract has an ultimate completion date of October 24, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,753.21 firm-fixed-price delivery order contract covers the provision of 4566821126 ONDANSETRON ODT 4 MG TABLET 30S, with a performance completion date of January 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,616.65 firm fixed-price delivery order is for the supply of 4566861815 ! ONDANSETRON ODT 8 MG TABLET 30S, with a completion date of January 8, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,424.24, is for the delivery of 4566844259 - ONDANSETRON ODT 4 MG TABLET 30S. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, for the delivery of 4565105865 - ONDANSETRON ODT 8 MG TABLET 30S. The contract has a ceiling value of $8,330.88 and a completion date of July 11, 2024. It is a Firm Fixed Price Delivery Order contract awarded without any set-aside designations. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,462.29 firm fixed-price delivery order is for the supply of 4566779255 - ONDANSETRON ODT 4 MG TABLET 30S, with a completion date of December 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $10,735.20 firm-fixed-price delivery order is for the supply of 4566075007 - ONDANSETRON ODT 4 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of October 11, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
This federal contract award, valued at $17,241.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4566825663 ! ONDANSETRON ODT 8 MG TABLET 30S, a critical medication used in healthcare settings. The contract has an ultimate completion date of January 3, 2025 and is a Firm Fixed Price arrangement. Notably, this award is part of a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,270.46 firm fixed-price delivery order contract is for the supply of 4564676092 ONDANSETRON ODT 4 MG TABLET 30S, with a completion date of May 22, 2024. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This federal contract award, valued at $1,785.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566758372 ONDANSETRON ODT 8 MG TABLET 30S, a pharmaceutical product, with a completion date of December 19, 2024. This contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX8JT
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $3,864.85 firm fixed-price delivery order is for the supply of 4566915206 - ONDANSETRON ODT 8 MG TABLET 30S, with a completion date of January 14, 2025.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/14/25, 10:29 AM